Other 🇺🇸, United States
Hims & Hers provides weight-management consultations, prescriptions and ongoing care through its telehealth platforms. Its role in the GLP-1 market focuses on connecting consumers with treatment and support. This profile follows its platform growth, financial performance and acquisitions, including its expansion through Eucalyptus.
As of 2026-09-14 · USD · Recorded monthly observations
Last 12 months
Last 12 months
Hims & Hers says it has bought Eucalyptus, adding an established digital healthcare business in several overseas markets. Payments for the acquisition can total up to $1.15 billion, subject to conditions and adjustments.
Hims & HersGrow revenue at each location and build a commercial model that can scale across a clinic group.
Sanor never sells your personal information. By providing this information you agree to Sanor’s Privacy Policy and Terms of Service.
SANOR research follows the principles of ISO 20252:2019 and the ICC/ESOMAR International Code on Market, Opinion and Social Research and Data Analytics, and is conducted in line with our Independence Policy. Our published reports follow our Editorial Standards.
SANOR research is funded through advisory engagements and research licensing. We do not accept vendor sponsorship, paid placement, or advertising.
All publications are provided for general information only. They do not constitute medical, financial, or investment advice and do not account for the circumstances of any specific business or individual.
